AMRN Amarin Corporation plc
12.02USD-0.41%Mkt Cap: 252.05M $P/E: —1d ago
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers…
Industry Peers
Drug Manufacturers - General$1.06TUSDP/E 39.9
LLY
Eli Lilly and Company$1.01TUSDP/E 39.6
$622.84BUSDP/E 29.9
$479.52BUSDP/E 76.7
ABBV
AbbVie Inc.$458.43BUSDP/E 76.9
$335.37BUSDP/E 24.1
$352.29BUSDP/E 113.3
ROP
Roche Holding AG$327.37BUSDP/E 23.5
MRK
Merck & Co., Inc.$351.41BUSDP/E 112.9
ROG
Roche Holding AG$331.80BUSDP/E 21.4
$260.36BUSDP/E 22.9
$272.33BUSDP/E 21.6
$260.71BUSDP/E 25.2
NVS
Novartis AG$266.84BUSDP/E 22.5
$238.84BUSDP/E 25.7
$248.33BUSDP/E 23.9
$223.32BUSDP/E 25.7
$205.33BUSDP/E 24.4
AMGN
Amgen Inc.$217.60BUSDP/E 25.6
$182.09BUSD
Key Statistics
Company
Market Cap252.05M USD
Enterprise Value-52.52M USD
Revenue (TTM)186.23M USD
Gross Profit120.87M USD
Net Income (TTM)-38.80M USD
Revenue/Share8.92 USD
Last Price12.02 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees80
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)12.32
PEG0.81
EV/EBITDA2.49
EV/Revenue-0.28
P/S1.36
P/B0.57
EPS (TTM)-1.20
EPS (Forward)0.98
52W Range
11.832% of range20.90
52W High20.90 USD
52W Low11.83 USD
Profitability
Gross Margin56.57%
Oper. Margin-28.36%
EBITDA Margin-11.33%
Profit Margin-18.16%
ROE-8.45%
ROA-5.78%
Growth
Revenue Growth-42.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF6.73M USD
CapEx (TTM)—
FCF Margin-2.99%
FCF Yield-2.21%
Net Debt-307.47M USD
Net Debt/EBITDA14.58
Balance Sheet
Debt/Equity0.01
Current Ratio3.67
Quick Ratio2.49
Book Value/Sh21.12 USD
Cash/Share14.90 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateApr 11, 2025
Analyst Consensus
Rating—
Target (Mean)12.50 USD
Upside (mean)+4.0%
Target Range12.00 USD – 13.00 USD
12.00+4.0% to mean13.00
# Analysts2
Ownership
Shares Out.20.97M
Float19.41M
Insiders37.19%
Institutions20.78%
Short Interest
Short Ratio6.3d
Short % Float2.54%
Short % Out.2.49%
Shares Short525.85K
Short (prev mo.)525.68K
Technical
SMA 5013.81 (-12.9%)
SMA 20014.53 (-17.3%)
Beta0.77
S&P 52W Chg16.45%
Avg Vol (30d)63.31K
Avg Vol (10d)67.30K
Technical Indicators
RSI (14)24.2
MACD-0.4939
MACD Signal-0.3461
MACD Hist.-0.1478
BB Upper14.78 USD
BB Middle13.31 USD
BB Lower11.84 USD
BB Width22.11%
ATR (14)0.4061 USD
Vol Ratio (20d)1.23x